ATE474580T1 - Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend - Google Patents

Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend

Info

Publication number
ATE474580T1
ATE474580T1 AT06075322T AT06075322T ATE474580T1 AT E474580 T1 ATE474580 T1 AT E474580T1 AT 06075322 T AT06075322 T AT 06075322T AT 06075322 T AT06075322 T AT 06075322T AT E474580 T1 ATE474580 T1 AT E474580T1
Authority
AT
Austria
Prior art keywords
norethisterone
male contraception
composition containing
testosterone
males
Prior art date
Application number
AT06075322T
Other languages
English (en)
Inventor
Ursula-Friederike Habenicht
Axel Kamischke
Eberhard Nieschlag
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE474580T1 publication Critical patent/ATE474580T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT06075322T 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend ATE474580T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15

Publications (1)

Publication Number Publication Date
ATE474580T1 true ATE474580T1 (de) 2010-08-15

Family

ID=26071832

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01902590T ATE355844T1 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend
AT06075322T ATE474580T1 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01902590T ATE355844T1 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend

Country Status (26)

Country Link
EP (2) EP1666044B1 (de)
JP (1) JP2003522795A (de)
KR (1) KR20020086905A (de)
CN (1) CN1423560A (de)
AT (2) ATE355844T1 (de)
AU (1) AU2001230447A1 (de)
BG (1) BG107066A (de)
BR (1) BR0108411A (de)
CA (1) CA2398063A1 (de)
CY (1) CY1106639T1 (de)
CZ (1) CZ20022691A3 (de)
DE (2) DE60127103T2 (de)
DK (1) DK1267885T3 (de)
EE (1) EE200200454A (de)
ES (1) ES2282230T3 (de)
HK (1) HK1049442B (de)
HU (1) HUP0300128A3 (de)
IL (1) IL151219A0 (de)
MX (1) MXPA02007675A (de)
NO (1) NO20023607L (de)
PL (1) PL357185A1 (de)
PT (1) PT1267885E (de)
RU (1) RU2002124602A (de)
SI (1) SI1267885T1 (de)
SK (1) SK11602002A3 (de)
WO (1) WO2001060376A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
MXPA05001024A (es) 2002-07-24 2005-05-16 Schering Ag Metodo microbiologico para la produccion de 11 alfa-hdiroxiesteroides sustituidos en la posicion 7 alfa.
JP2006502997A (ja) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト アンドロゲン１１β‐ハロゲンステロイドおよびゲスタゲンを含有する組成物ならびにこの組成物に基づく男性用避妊薬
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
IL277372B2 (en) 2018-03-23 2023-09-01 Laboratoires Major Non-hormonal preparations including (r)-silodosin and male contraceptive methods, including once-daily administration of (r)-silodosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
JP2003522795A (ja) 2003-07-29
EE200200454A (et) 2003-12-15
PL357185A1 (en) 2004-07-26
AU2001230447A1 (en) 2001-08-27
EP1666044B1 (de) 2010-07-21
HK1049442A1 (en) 2003-05-16
NO20023607L (no) 2002-10-15
CZ20022691A3 (cs) 2003-01-15
SK11602002A3 (sk) 2003-03-04
KR20020086905A (ko) 2002-11-20
HK1049442B (zh) 2007-06-15
PT1267885E (pt) 2007-05-31
RU2002124602A (ru) 2004-03-10
WO2001060376A1 (en) 2001-08-23
DE60127103D1 (de) 2007-04-19
HUP0300128A3 (en) 2004-03-29
HUP0300128A2 (en) 2003-05-28
BG107066A (en) 2003-05-30
EP1666044A1 (de) 2006-06-07
IL151219A0 (en) 2003-04-10
EP1267885B1 (de) 2007-03-07
EP1267885B8 (de) 2007-06-20
SI1267885T1 (sl) 2007-08-31
ATE355844T1 (de) 2007-03-15
CY1106639T1 (el) 2012-01-25
NO20023607D0 (no) 2002-07-30
BR0108411A (pt) 2003-03-11
CA2398063A1 (en) 2001-08-23
DE60142647D1 (de) 2010-09-02
CN1423560A (zh) 2003-06-11
ES2282230T3 (es) 2007-10-16
EP1267885A1 (de) 2003-01-02
MXPA02007675A (es) 2004-02-26
DK1267885T3 (da) 2007-07-09
DE60127103T2 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
CA2084891A1 (en) Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
NO20032805D0 (no) Preparater av östrogensyklodekstrinkomplekser
ES2123547T3 (es) Formulaciones, metodos y dispositivos contraceptivos transdermicos.
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
KR970010784A (ko) 11-(치환된 페닐)-에스트라-4,9-디엔 유도체
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
EP1513588B1 (de) Verwendung neuer etonogestrelester
JP2003522795A5 (de)
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
IE34308B1 (en) 11beta,13beta dialkylgona-1,3,5(10)-trien-3-ol 3-cycloalkyl ethers
AU2002222073A1 (en) Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least an antimicrobial agent
GB9807809D0 (en) Compositions comprising ethisterone or its derivatives
AU1047002A (en) 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina
GB1060632A (en) Steroid compositions
JPS5936611A (ja) 粘着性貼付製剤
AR018349A1 (es) Composicion farmaceutica que comprende estrogenos y antiestrogenos y su uso para la manufactura de un medicamento
CU22840A1 (es) Derivados esteroidales de la serie del androstano sustituídos en el anillo c que presentan marcada actividad anabólica e insignificante actividad androgénica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties